Vitamin D and white matter abnormalities in older adults: A quantitative volumetric analysis of brain MRI

Experimental Gerontology

Volumn 63, Issue , 2015, Pages 41-47

  Annweiler, Cédric ^a,b,c   Bartha, Robert ^c   Karras, Spyridon N ^d   Gautier, Jennifer ^b   Roche, Frédéric ^e   Beauchet, Olivier ^a,b,f  

^a UNIVERSITÉ D'ANGERS   (France)

^b Research Center on Autonomy and Longevity (CeRAL)   (France)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITÉ LYON 1   (France)

^f Biomathics   (France)

Author keywords

Brain; Leukoaraiosis; Magnetic resonance imaging; Older adults; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; 25-HYDROXYVITAMIN D; VITAMIN D;

ACTIVITY OF DAILY LIVING ASSESSMENT; AGE; AGED; ARTICLE; BODY MASS; BRAIN SIZE; CALCIUM BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING; MALE; MEAN ARTERIAL PRESSURE; MEASUREMENT ACCURACY; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SEASONAL VARIATION; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WHITE MATTER; WHITE MATTER ABNORMALITY; AGING; ANALOGS AND DERIVATIVES; BLOOD; GERIATRIC ASSESSMENT; PATHOPHYSIOLOGY; SCINTISCANNING;

AGED; AGING; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; VITAMIN D; VITAMIN D DEFICIENCY; WHITE MATTER;

EID: 84922362663     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.01.049     Document Type: Article

References (52)

1. Abraham P.S., Calès S., Redureau E., Fantino B., De Decker L., Beauchet O., Annweiler C. The vitamin "D-bate": what vascular risk in geriatric inpatients?. J. Am. Geriatr. Soc. 2011, 59:1556-1558.
2. Annweiler C., Beauchet O. Questioning vitamin D status of senior fallers and non-fallers: a meta-analysis to address a forgotten step. J. Intern. Med. 2015, 277:16-44.
3. Annweiler C., Montero-Odasso M. Vascular burden as a substrate for higher-level gait disorders in older adults. A review of brain mapping literature. Panminerva Med. 2012, 54:189-204.
4. Annweiler C., Allali G., Allain P., et al. Vitamin D and cognitive performance in adults: a systematic review. Eur. J. Neurol. 2009, 16:1083-1089.
5. Annweiler C., Schott A.M., Berrut G., Fantino B., Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J. Nutr. Health Aging 2009, 13:893-898.
6. Annweiler C., Schott A.M., Berrut G., et al. Vitamin D and ageing: neurological issues. Neuropsychobiology 2010, 62:139-150.
7. Annweiler C., Souberbielle J.C., Schott A.M., de Decker L., Berrut G., Beauchet O. Vitamin D in the elderly: 5 points to remember. Geriatr. Psychol. Neuropsychiatr. Vieil. 2011, 9:259-267.
8. Annweiler C., Fantino B., Schott A.M., Krolak-Salmon P., Allali G., Beauchet O. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur. J. Neurol. 2012, 19:1023-1029.
9. Annweiler C., Montero-Odasso M., Muir S.W., Beauchet O. Vitamin D and brain imaging in the elderly: should we expect some lesions specifically related to hypovitaminosis D?. Open Neuroimaging J. 2012, 6:16-18.
10. Annweiler C., Montero-Odasso M., Hachinski V., Seshadri S., Bartha R., Beauchet O. Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol. Nutr. Food Res. 2013, 57:267-276.
11. Annweiler C., Annweiler T., Montero-Odasso M., Bartha R., Beauchet O. Vitamin D and brain volumetric changes: systematic review and meta-analysis. Maturitas 2014, 78:30-39.
12. Annweiler C., Beauchet O., Bartha R., Hachinski V., Montero-Odasso M. Vitamin D and caudal primary motor cortex: a magnetic resonance spectroscopy study. PLoS One 2014, 9:e87314.
13. Bagnato F., Jeffries N., Richert N.D., et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4years. Brain 2003, 126:1782-1789.
14. Barrett P.H., Okawa G., Bowman J. Evidence-based guidelines. Perm. J. 2005, 9:83-88.
15. Bowman G.L., Silbert L.C., Howieson D., et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78:241-249.
16. Brøndum-Jacobsen P., Nordestgaard B.G., Schnohr P., Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann. Neurol. 2013, 73:38-47.
17. Brown J., Bianco J.I., McGrath J.J., Eyles D.W. 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 2003, 343:139-143.
18. Buell J.S., Dawson-Hughes B., Scott T.M., et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26.
19. Burns J.M., Church J.A., Johnson D.K., et al. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch. Neurol. 2005, 62:1870-1876.
20. Camp S.J., Stevenson V.L., Thompson A.J., et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005, 128:2891-2898.
21. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666.
22. Eggert L.D., Sommer J., Jansen A., et al. Accuracy and reliability of automated gray matter segmentation pathways on real and simulated structural magnetic resonance images of the human brain. PLoS One 2012, 7:e45081.
23. Etgen T., Sander D., Bickel H., Sander K., Forstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 2012, 33:297-305.
24. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience 2003, 118:641-653.
25. Farid K., Volpe-Gillot L., Petras S., Plou C., Caillat-Vigneron N., Blacher J. Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia. Nucl. Med. Commun. 2012, 33:1048-1052.
26. Fazekas F., Schmidt R., Scheltens P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement. Geriatr. Cogn. Disord. 1998, 9:2-5.
27. Fischl B., Salat D.H., Busa E., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
28. Fischl B., Salat D.H., Van Der Kouwe A.J.W., et al. Sequence independent segmentation of magnetic resonance images. NeuroImage 2004, 23:S69-S84.
29. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
30. Ford E.S., Ajani U.A., McGuire L.C., Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 2005, 28:1228-1230.
31. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
32. Gass A., Oster M., Cohen S., Daffertshofer M., Schwartz A., Hennerici M.G. Assessment of T2- and T1-weighted MRI brain lesion load in patients with subcortical vascular encephalopathy. Neuroradiology 1998, 40:503-506.
33. Han X., Jovicich J., Salat D., et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 2006, 32:180-194.
34. Hossein-Nezhad A., Holick M.F. Vitamin D for health: a global perspective. Mayo Clin. Proc. 2013, 88:720-755.
35. Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D. Committee to Review Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, Institute of Medicine, Washington DC.
36. Izzo J.L., Sica D.A., Black H.R. Hypertension primer: the essentials of high blood pressure. Basic Science, Population Science, and Clinical Management 2008, American Heart Association, Dallas. 4th ed.
37. Jacobs H.I., Leritz E.C., Williams V.J., et al. Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health. Hum. Brain Mapp. 2013, 34:77-95.
38. Kalueff A.V., Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:12-19.
39. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 2002, 110:229-238.
40. Manolio T.A., Kronmal R.A., Burke G.L., et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994, 25:318-327.
41. Mateus-Hamdan L., Beauchet O., Rolland Y., Schott A.M., Annweiler C. Association of calcium concentration with pulse pressure in older women: a large population-based multicentric study. J. Nutr. Health Aging 2014, 18:323-329.
42. Melamed M.L., Muntner P., Michos E.D., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1179-1185.
43. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
44. Pérès K., Chrysostome V., Fabrigoule C., Orgogozo J.M., Dartigues J.F., Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 2006, 67:461-466.
45. Prager J.M., Thomas C., Ankenbrandt W.J., et al. Association of white matter hyperintensities with low serum 25-hydroxyvitamin D levels. AJNR Am. J. Neuroradiol. 2014, 35:1145-1149.
46. Rochon J., Gondan M., Kieser M. To test or not to test: preliminary assessment of normality when comparing two independent samples. BMC Med. Res. Methodol. 2012, 12:81.
47. Salat D.H., Tuch D.S., van der Kouwe A.J., et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging 2010, 31:244-256.
48. Schmidt R., Enzinger C., Ropele S., et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003, 361:2046-2048.
49. Smith C.D., Snowdon D., Markesbery W.R. Periventricular white matter hyperintensities on MRI: correlation with neuropathologic findings. J. Neuroimaging 2000, 10:13-16.
50. Vannier-Nitenberg C., Dauphinot V., Bongue B., et al. Early detection of memory impairment in people over 65years old consulting at Health Examination Centers for the French health insurance: the EVATEM protocol. BMC Geriatr. 2013, 13:55.
51. Willey J.Z., Scarmeas N., Provenzano F.A., Luchsinger J.A., Mayeux R., Brickman A.M. White matter hyperintensity volume and impaired mobility among older adults. J. Neurol. 2013, 260:884-890.
52. World Health Organization Prevention and Management of Osteoporosis: Report of a WHO Scientific Group 2003, World Health Organization, Geneva.